Q&A: ‘Trial failure due to recruitment is a thing of the past thanks to AI’
CEO of H1 Ariel Katz’s mission is ‘to connect the world to the right doctor’ with a focus on connecting sponsors with the right PIs.
AbbVie’s venetoclax fails Phase III myeloma trial
Novartis eyes accelerated FDA approval for iptacopan across multiple indications
Signal: Philips knew about ventilator defects for years before recall
Regeneron’s linvoseltamab shows early and durable response in pre-treated MM
PercAssist implants first patient with extravascular cardiac assistance device
Analysis
View More
Themes
View MoreGritstone bio secures contract for Phase IIb Covid-19 vaccine trial
As part of the BARDA contract, Gritstone bio will launch a Phase IIb vaccine trial enrolling 10,000 subjects.
More themes
Premium Insights
View MoreLeading innovators with viral vectors for the pharmaceutical industry
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Discover premium insights powered by our properietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
Medidata unveils new solution to boost clinical trial diversity
Corporate sustainability needs ESG standards and tools
Invivyd doses first patient in Covid-19 therapy trial
Is long Covid linked to Alzheimer’s disease?